Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta - PubMed (original) (raw)
. 2000 Oct 31;102(18):2262-8.
doi: 10.1161/01.cir.102.18.2262.
M Laitinen, M P Turunen, M Jeltsch, J Hartikainen, T T Rissanen, J Laukkanen, M Niemi, M Kossila, T P Häkkinen, A Kivelä, B Enholm, H Mansukoski, A M Turunen, K Alitalo, S Ylä-Herttuala
Affiliations
- PMID: 11056103
- DOI: 10.1161/01.cir.102.18.2262
Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta
M O Hiltunen et al. Circulation. 2000.
Abstract
Background: Gene transfer to the vessel wall may provide new possibilities for the treatment of vascular disorders, such as postangioplasty restenosis. In this study, we analyzed the effects of adenovirus-mediated vascular endothelial growth factor (VEGF)-C gene transfer on neointima formation after endothelial denudation in rabbits. For comparison, a second group was treated with VEGF-A adenovirus and a third group with lacZ adenovirus. Clinical-grade adenoviruses were used for the study.
Methods and results: Aortas of cholesterol-fed New Zealand White rabbits were balloon-denuded, and gene transfer was performed 3 days later. Animals were euthanized 2 and 4 weeks after the gene transfer, and intima/media ratio (I/M), histology, and cell proliferation were analyzed. Two weeks after the gene transfer, I/M in the lacZ-transfected control group was 0. 57+/-0.04. VEGF-C gene transfer reduced I/M to 0.38+/-0.02 (P:<0.05 versus lacZ group). I/M in VEGF-A-treated animals was 0.49+/-0.17 (P:=NS). The tendency that both VEGF groups had smaller I/M persisted at the 4-week time point, when the lacZ group had an I/M of 0.73+/-0.16, the VEGF-C group 0.44+/-0.14, and the VEGF-A group 0. 63+/-0.21 (P:=NS). Expression of VEGF receptors 1, 2, and 3 was detected in the vessel wall by immunocytochemistry and in situ hybridization. As an additional control, the effect of adenovirus on cell proliferation was analyzed by performing gene transfer to intact aorta without endothelial denudation. No differences were seen in smooth muscle cell proliferation or I/M between lacZ adenovirus and 0.9% saline-treated animals.
Conclusions: Adenovirus-mediated VEGF-C gene transfer may be useful for the treatment of postangioplasty restenosis and vessel wall thickening after vascular manipulations.
Similar articles
- Intravascular adenovirus-mediated lipoprotein-associated phospholipase A2 gene transfer reduces neointima formation in balloon-denuded rabbit aorta.
Turunen P, Puhakka H, Rutanen J, Hiltunen MO, Heikura T, Gruchala M, Ylä-Herttuala S. Turunen P, et al. Atherosclerosis. 2005 Mar;179(1):27-33. doi: 10.1016/j.atherosclerosis.2004.10.025. Epub 2004 Dec 13. Atherosclerosis. 2005. PMID: 15721006 - Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor.
Gennaro G, Ménard C, Michaud SE, Rivard A. Gennaro G, et al. Circulation. 2003 Jan 21;107(2):230-3. doi: 10.1161/01.cir.0000050652.47145.4c. Circulation. 2003. PMID: 12538420 - Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits.
Leppänen O, Rutanen J, Hiltunen MO, Rissanen TT, Turunen MP, Sjöblom T, Brüggen J, Bäckström G, Carlsson M, Buchdunger E, Bergqvist D, Alitalo K, Heldin CH, Ostman A, Ylä-Herttuala S. Leppänen O, et al. Circulation. 2004 Mar 9;109(9):1140-6. doi: 10.1161/01.CIR.0000117234.08626.7C. Epub 2004 Feb 9. Circulation. 2004. PMID: 14769706 - Learning from vascular remodelling.
Martin J. Martin J. Clin Exp Allergy. 2000 Jun;30 Suppl 1:33-6. doi: 10.1046/j.1365-2222.2000.00094.x. Clin Exp Allergy. 2000. PMID: 10849472 Review. - Gene transfer strategies to inhibit neointima formation.
Crook MF, Akyürek LM. Crook MF, et al. Trends Cardiovasc Med. 2003 Apr;13(3):102-6. doi: 10.1016/s1050-1738(02)00255-4. Trends Cardiovasc Med. 2003. PMID: 12691673 Review.
Cited by
- Gene therapy for restenosis: current status.
Rutanen J, Markkanen J, Ylä-Herttuala S. Rutanen J, et al. Drugs. 2002;62(11):1575-85. doi: 10.2165/00003495-200262110-00001. Drugs. 2002. PMID: 12109921 Review. - In vitro biocompatibility and endothelialization of novel magnesium-rare Earth alloys for improved stent applications.
Zhao N, Watson N, Xu Z, Chen Y, Waterman J, Sankar J, Zhu D. Zhao N, et al. PLoS One. 2014 Jun 12;9(6):e98674. doi: 10.1371/journal.pone.0098674. eCollection 2014. PLoS One. 2014. PMID: 24921251 Free PMC article. - Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis.
Lee T, Roy-Chaudhury P. Lee T, et al. Adv Chronic Kidney Dis. 2009 Sep;16(5):329-38. doi: 10.1053/j.ackd.2009.06.009. Adv Chronic Kidney Dis. 2009. PMID: 19695501 Free PMC article. Review. - Therapeutic myocardial angiogenesis with vascular endothelial growth factors.
Yoon YS, Johnson IA, Park JS, Diaz L, Losordo DW. Yoon YS, et al. Mol Cell Biochem. 2004 Sep;264(1-2):63-74. doi: 10.1023/b:mcbi.0000044375.33928.62. Mol Cell Biochem. 2004. PMID: 15544036 Review. - Bioactive baculovirus nanohybrids for stent based rapid vascular re-endothelialization.
Paul A, Elias CB, Shum-Tim D, Prakash S. Paul A, et al. Sci Rep. 2013;3:2366. doi: 10.1038/srep02366. Sci Rep. 2013. PMID: 23917680 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous